Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pharmacokinetic/Pharmacodynamic Genetic Variation Treatment Algorithm Versus Treatment As Usual for Adolescent Management Of Depression (Abbreviation Assurex AMOD)

NCT02286440 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT02286440
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02286440 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pharmacokinetic/Pharmacodynamic Genetic Variation Treatment Algorithm Versus Treatment As Usual for Adolescent Management Of Depression (Abbreviation Assurex AMOD)
Lead sponsor
Mayo Clinic
Phase
Not applicable
Overall status
Completed
Start date
February 28, 2015
Completion date
February 6, 2019
Enrollment
179 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

depression